Observe Medical ASA Board of Directors has onJanuary 9 2020 , as part of a long-term incentive plan, approved grantingBjörn Larsson (CEO inObserve Medical ASA ) 60 000 series A options and 60 000 series B options. Each option, when exercised, will give the right to acquire one share inObserve Medical ASA . The options are granted without consideration. The series A options are granted vest over a 3 year period, with 1/3 after 12 months, 1/3 after 24 months and the last third after 36 months. The series A option shares have a 12 month lock-up period tied to them. Options that have not been exercised will lapse 3.5 years after grant date. The series B options are granted vest on the date of the option agreement. The series B option shares have a 24 month lock-up period tied to them. Options that have not been exercised will lapse as ofJanuary 1 2021 . The strike price for the options isNOK 11.09 and calculated as the average price the last 10 trading days before signing of the option agreement. This information is subject to the disclosure requirements pursuant to section 4-2 of the Norwegian Securities Trading Act.
Click here for more information
© Oslo Bors ASA, source